-
PIONEER Patient Testimonials
June 5, 2019Patient representatives, Erik Briers and Ken Mastris, reflect on the relevance of PIONEER for prostate cancer patients.
0 -
Introducing PIONEER Health Europa Quarterly
May 7, 2019Professor Dr James N’Dow explains how the PIONEER project will unlock the power of big data and big data...
-
Job Advert: Research Associate Vita-Salute San Raffaele University in Milan
April 2, 2019An exciting 3 year opportunity has arisen for a talented research associate within work package 2 of PIONEER at...
-
Wie Big Data bei Patienten mit Prostatakrebs helfen können
May 23, 2018Wie Big Data bei Patienten mit Prostatakrebs helfen können Innovative Medicines Initiative genehmigt 12 Millionen Euro umfassendes, öffentlich-privates Forschungsprojekt...
-
We need you – Patient involvement is vital to the success of PIONEER
May 23, 2018A critical requirement of the PIONEER project is to agree on and prioritise the most important questions in Prostate...
-
Cómo el Big Data (Macrodatos) puede ayudar a los pacientes con cáncer de próstata
May 23, 2018Cómo el Big Data (Macrodatos) puede ayudar a los pacientes con cáncer de próstata La Innovative Medicines Initiative (IMI)...
-
Using #RWD to fill the knowledge gap
May 16, 2018Carlos Moedas, Commissioner on Research, Science and Innovation of the European Commission tweeted: “Using #RWD to fill the knowledge gap: clinical...
-
How big data can help Prostate Cancer patients
May 14, 2018Press Release: How big data can help Prostate Cancer patients Innovative Medicines Initiative approves € 12 million public-private research...
Contact us here
PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
